Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective, observational, multicenter study on risk factors and prophylaxis for low emetic risk chemotherapy-induced nausea and vomiting.
Hayashi T, Shimokawa M, Miyoshi T, Toriyama Y, Yokota C, Taniguchi J, Hanada K, Tsumagari K, Okubo N, Koutake Y, Sakata K, Kawamata Y, Goto T, Tsurusaki Y, Koyabu M. Hayashi T, et al. Among authors: koutake y. Support Care Cancer. 2017 Sep;25(9):2707-2714. doi: 10.1007/s00520-017-3679-7. Epub 2017 Mar 24. Support Care Cancer. 2017. PMID: 28341971
Risk factors for delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy: a prospective, observational, multicenter study.
Hayashi T, Shimokawa M, Matsuo K, Miyoshi T, Toriyama Y, Yokota C, Taniguchi J, Hanada K, Tsumagari K, Okubo N, Koutake Y, Sakata K, Kawamata Y, Goto T, Tsurusaki Y, Koyabu M. Hayashi T, et al. Among authors: koutake y. Cancer Manag Res. 2018 Oct 4;10:4249-4255. doi: 10.2147/CMAR.S176574. eCollection 2018. Cancer Manag Res. 2018. PMID: 30323680 Free PMC article.
Association between pretreatment neutrophil-to-lymphocyte ratio and immune-related adverse events due to immune checkpoint inhibitors in patients with non-small cell lung cancer.
Fujimoto A, Toyokawa G, Koutake Y, Kimura S, Kawamata Y, Fukuishi K, Yamazaki K, Takeo S. Fujimoto A, et al. Among authors: koutake y. Thorac Cancer. 2021 Aug;12(15):2198-2204. doi: 10.1111/1759-7714.14063. Epub 2021 Jun 26. Thorac Cancer. 2021. PMID: 34173724 Free PMC article.
Predictors for the Clinical Efficacy of Tramadol for Cancer Pain.
Koutake Y, Fujimoto A, Nakahara M, Tsuruyama M, Miyoshi T, Yamaguchi Y, Fukazawa M, Kawamata Y, Hanada K, Hashimoto M. Koutake Y, et al. Am J Hosp Palliat Care. 2023 Dec;40(12):1303-1309. doi: 10.1177/10499091231152854. Epub 2023 Jan 16. Am J Hosp Palliat Care. 2023. PMID: 36647180
Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study.
Fujimoto A, Koutake Y, Hisamatsu D, Ookubo N, Yabuuchi Y, Kamimura G, Kai T, Kozono A, Ootsu T, Suzuki H, Matsuo K, Kuwahara K, Oiwane Y, Nagata Y, Tanimoto K, Sato E, Suenaga M, Uehara T, Ikari A, Endo S, Hiraki Y, Kawamata Y. Fujimoto A, et al. Among authors: koutake y. Cancer Immunol Immunother. 2023 Jul;72(7):2169-2178. doi: 10.1007/s00262-023-03408-4. Epub 2023 Feb 27. Cancer Immunol Immunother. 2023. PMID: 36849845 Free PMC article.